Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Effects of an Integrative Mind-Body-Medicine Group Program on Breast Cancer Patients During Chemotherapy: An Observational Study

Author(s): Heidemarie Haller, Kyung-Eun Choi, Silke Lange, Sherko Kümmel, Anna Paul, Holger Cramer, Gustav Dobos and Petra Voiss*

Volume 27, Issue 8, 2021

Published on: 10 December, 2020

Page: [1112 - 1120] Pages: 9

DOI: 10.2174/1381612826666201211111122

Price: $65

Abstract

Background: Breast cancer is one of the leading cancers in women in the Western world. Cancer treatment, especially chemotherapy, is often associated with physical and psychosocial side effects.

Objective: To improve the quality of life and manage side effects, a new integrative mind-body-medicine group concept for breast cancer patients receiving chemotherapy was developed and pilot tested.

Methods: Breast cancer patients participated in a 66 hours mind-body-medicine group program tailored to the needs of cancer patients during chemotherapy. The program was integrated into standard care encompassing mindfulness training, yoga, moderate exercise, nutrition, complementary self-help strategies, cognitive restructuring, and acupuncture. Quality of life (EORTC QLQ-C30), depression and anxiety (HADS), stress (PSS-10), and fatigue (BFI) were assessed before and after the program, as well as satisfaction and safety. Analyses were carried out on exploratory basis with paired samples t-tests.

Results: Fifty-seven female patients, aged 51.3±10.5 years, with breast cancer diagnoses were enrolled. After completing the program, global EORTC quality of life was improved (D=9.5; 95%-CI=[2.9|16.1]; p=.005), although the EORTC-symptom scales assessing fatigue (D=9.9; 95%-CI=[1|18.8]; p=.030), nausea (D=7.1; 95%- CI=[0.6|13.6]; p=.031), and dyspnea (D=12.5; 95%-CI=[2.9|22.1]; p=.011) were found to be increased. Stress (D=-3.5; 95%-CI=[-5|-2.1]; p=.000), anxiety (D=-3.8; 95%-CI=[-4.9|-2.7]; p=.000) and depression (D=-3.9; 95%-CI=[-4.9|-2.8]; p=.000) were also found to be significantly reduced. Regarding the severity of (D=0.2; 95%- CI=[-0.8|0.5]; p=.644) and the impairment due to fatigue (D=0.1; 95%-CI=[-0.8|0.6]; p=.696), no significant worsening was observed. Patients were satisfied with the program. No serious adverse events were reported.

Conclusion: Breast cancer patients benefit from an integrative mind-body-medicine group program during chemotherapy regarding the quality of life and psychological symptoms. Randomized controlled trials are warranted.

Keywords: Breast cancer, chemotherapy, mind-body therapies, mindfulness-based stress reduction, acupuncture, quality of life, anxiety, depression.

« Previous
[1]
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-86.
[http://dx.doi.org/10.1002/ijc.29210] [PMID: 25220842]
[2]
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386(9995): 743-800.
[http://dx.doi.org/10.1016/S0140-6736(15)60692-4] [PMID: 26063472]
[3]
Barnes B. Bericht zum Krebsgeschehen in Deutschland 2016 Berlin: Robert Koch-Institut 2016. Available at: https://edoc.rki.de/handle/176904/3264
[4]
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545-602.
[http://dx.doi.org/10.1016/S0140-6736(16)31678-6] [PMID: 27733282]
[5]
Brandão T, Schulz MS, Matos PM. Psychological adjustment after breast cancer: a systematic review of longitudinal studies. Psychooncology 2017; 26(7): 917-26.
[http://dx.doi.org/10.1002/pon.4230] [PMID: 27440317]
[6]
Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 2016; 27(6): 965-74.
[http://dx.doi.org/10.1093/annonc/mdw099] [PMID: 26940687]
[7]
Alcântara-Silva TR, Freitas-Junior R, Freitas NM, Machado GD. Fatigue related to radiotherapy for breast and/or gynaecological cancer: a systematic review. J Clin Nurs 2013; 22(19-20): 2679-86.
[http://dx.doi.org/10.1111/jocn.12236] [PMID: 23651041]
[8]
Trudel-Fitzgerald C, Zhou ES, Poole EM, et al. Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study. Br J Cancer 2017; 116(9): 1239-46.
[http://dx.doi.org/10.1038/bjc.2017.85] [PMID: 28359077]
[9]
Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008; 5(8): 466-75.
[http://dx.doi.org/10.1038/ncponc1134] [PMID: 18493231]
[10]
Lin X, Chen W, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med 2015; 16(11): 1381-7.
[http://dx.doi.org/10.1016/j.sleep.2015.02.543] [PMID: 26498240]
[11]
Suppli NP, Johansen C, Kessing LV, et al. Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort Study. J Clin Oncol 2017; 35(3): 334-42.
[http://dx.doi.org/10.1200/JCO.2016.68.8358] [PMID: 28095267]
[12]
Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev 2017; 1CD010802
[http://dx.doi.org/10.1002/14651858.CD010802.pub2] [PMID: 28045199]
[13]
Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017; 67(3): 194-232.
[http://dx.doi.org/10.3322/caac.21397] [PMID: 28436999]
[14]
Lyman GH, Greenlee H, Bohlke K, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 2018; 36(25): 2647-55.
[http://dx.doi.org/10.1200/JCO.2018.79.2721] [PMID: 29889605]
[15]
Fremd C, Hack CC, Schneeweiss A, et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet 2017; 295(5): 1239-45.
[http://dx.doi.org/10.1007/s00404-017-4348-2] [PMID: 28331996]
[16]
Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. JAMA 2008; 300(11): 1350-2.
[http://dx.doi.org/10.1001/jama.300.11.1350] [PMID: 18799450]
[17]
Bishop SR. Mindfulness: a proposed operational definition. Clin Psychol Sci Pract 2004; 11: 230-41.
[http://dx.doi.org/10.1093/clipsy.bph077]
[18]
Baer RA. Mindfulness training as a clinical intervention: A conceptual and empirical review. Clin Psychol Sci Pract 2003; 10: 125-43.
[http://dx.doi.org/10.1093/clipsy.bpg015]
[19]
Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York: Delta Trade Paperback/Bantam Dell 1990.
[20]
Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68(4): 615-23.
[http://dx.doi.org/10.1037/0022-006X.68.4.615] [PMID: 10965637]
[21]
Crane R. Mindfulness-based cognitive therapy: distinctive features. New York, NY: Routledge/Taylor & Francis Group 2009.
[22]
Haller H, Winkler MM, Klose P, Dobos G, Kümmel S, Cramer H. Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta Oncol 2017; 56(12): 1665-76.
[http://dx.doi.org/10.1080/0284186X.2017.1342862] [PMID: 28686520]
[23]
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol 2012; 30(12): 1335-42.
[http://dx.doi.org/10.1200/JCO.2010.34.0331] [PMID: 22430268]
[24]
Lengacher CA. A Large Randomized Trial: Effects of Mindfulness-Based Stress Reduction (MBSR) for Breast Cancer (BC) Survivors on Salivary Cortisol and IL-6. Biol Res Nurs 2019; 21(1): 39-49.
[PMID: 30079756]
[25]
Reich RR, Lengacher CA, Alinat CB, et al. Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters. J Pain Symptom Manage 2017; 53(1): 85-95.
[http://dx.doi.org/10.1016/j.jpainsymman.2016.08.005] [PMID: 27720794]
[26]
Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat 2012; 131(1): 99-109.
[http://dx.doi.org/10.1007/s10549-011-1738-1] [PMID: 21901389]
[27]
Würtzen H, Dalton SO, Elsass P, et al. Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer. Eur J Cancer 2013; 49(6): 1365-73.
[http://dx.doi.org/10.1016/j.ejca.2012.10.030] [PMID: 23265707]
[28]
Jeitler M, Jaspers J, von Scheidt C, et al. Mind-body medicine and lifestyle modification in supportive cancer care: A cohort study on a day care clinic program for cancer patients. Psychooncology 2017; 26(12): 2127-34.
[http://dx.doi.org/10.1002/pon.4433] [PMID: 28370730]
[29]
Jong MC, Boers I, Schouten van der Velden AP, et al. A Randomized Study of Yoga for Fatigue and Quality of Life in Women with Breast Cancer Undergoing (Neo) Adjuvant Chemotherapy. J Altern Complement Med 2018; 24(9-10): 942-53.
[http://dx.doi.org/10.1089/acm.2018.0191] [PMID: 30247961]
[30]
Lötzke D, Wiedemann F, Rodrigues Recchia D, et al. Iyengar-Yoga Compared to Exercise as a Therapeutic Intervention during (Neo)adjuvant Therapy in Women with Stage I-III Breast Cancer: Health-Related Quality of Life, Mindfulness, Spirituality, Life Satisfaction, and Cancer-Related Fatigue. Evid Based Complement Alternat Med 2016; 20165931816
[http://dx.doi.org/10.1155/2016/5931816] [PMID: 27019663]
[31]
Chaoul A, Milbury K, Spelman A, et al. Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy. Cancer 2018; 124(1): 36-45.
[http://dx.doi.org/10.1002/cncr.30938] [PMID: 28940301]
[32]
Spahn G, Choi KE, Kennemann C, et al. Can a multimodal mind-body program enhance the treatment effects of physical activity in breast cancer survivors with chronic tumor-associated fatigue? A randomized controlled trial. Integr Cancer Ther 2013; 12(4): 291-300.
[http://dx.doi.org/10.1177/1534735413492727] [PMID: 23766391]
[33]
Dobos G, Overhamm T, Büssing A, et al. Integrating mindfulness in supportive cancer care: a cohort study on a mindfulness-based day care clinic for cancer survivors. Support Care Cancer 2015; 23(10): 2945-55.
[http://dx.doi.org/10.1007/s00520-015-2660-6] [PMID: 25711654]
[34]
Golden-Kreutz DM, Browne MW, Frierson GM, Andersen BL. Assessing stress in cancer patients: a second-order factor analysis model for the Perceived Stress Scale. Assessment 2004; 11(3): 216-23.
[http://dx.doi.org/10.1177/1073191104267398] [PMID: 15358877]
[35]
Golden-Kreutz DM, Thornton LM, Wells-Di Gregorio S, et al. Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. Health Psychol 2005; 24(3): 288-96.
[http://dx.doi.org/10.1037/0278-6133.24.3.288] [PMID: 15898865]
[36]
Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 27: 32.
[http://dx.doi.org/10.1186/1756-9966-27-32] [PMID: 18759983]
[37]
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365-76.
[http://dx.doi.org/10.1093/jnci/85.5.365] [PMID: 8433390]
[38]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-70.
[http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x] [PMID: 6880820]
[39]
Radbruch L, Sabatowski R, Elsner F, Everts J, Mendoza T, Cleeland C. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage 2003; 25(5): 449-58.
[http://dx.doi.org/10.1016/S0885-3924(03)00073-3] [PMID: 12727043]
[40]
Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85(5): 1186-96.
[http://dx.doi.org/10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N] [PMID: 10091805]
[41]
Cohen S, Janicki-Deverts D. Who’s Stressed? Distributions of Psychological Stress in the United States in Probability Samples from 1983, 2006, and 20091. J Appl Soc Psychol 2012; 42(6): 1320-34.
[http://dx.doi.org/10.1111/j.1559-1816.2012.00900.x]
[42]
Paul A, Cramer H, Lauche R, Altner N, Langhorst J, Dobos GJ. An oncology mind-body medicine day care clinic: concept and case presentation. Integr Cancer Ther 2013; 12(6): 503-7.
[http://dx.doi.org/10.1177/1534735412473639] [PMID: 23329568]
[43]
Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982; 4(1): 33-47.
[http://dx.doi.org/10.1016/0163-8343(82)90026-3] [PMID: 7042457]
[44]
Benson H, Stuart M. The wellness book Mind-body medicine. New York, NY: Fireside 1999.
[45]
Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol 2006; 62(3): 373-86.
[http://dx.doi.org/10.1002/jclp.20237] [PMID: 16385481]
[46]
Cormie P, Atkinson M, Bucci L, et al. Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 2018; 209(4): 184-7.
[http://dx.doi.org/10.5694/mja18.00199] [PMID: 29719196]
[47]
Ancoli-Israel S, Liu L, Rissling M, et al. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer 2014; 22(9): 2535-45.
[http://dx.doi.org/10.1007/s00520-014-2204-5] [PMID: 24733634]
[48]
Grassi L, Berardi MA, Ruffilli F, et al. IOR-IRST Psycho-Oncology and UniFE Psychiatry Co-Authors. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom 2015; 84(6): 339-47.
[http://dx.doi.org/10.1159/000431256] [PMID: 26402426]
[49]
Alawadi SA, Ohaeri JU. Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. BMC Cancer 2009; 9: 222.
[http://dx.doi.org/10.1186/1471-2407-9-222] [PMID: 19586536]
[50]
Mijwel S, Backman M, Bolam KA, et al. Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial. Breast Cancer Res Treat 2018; 168(1): 79-93.
[http://dx.doi.org/10.1007/s10549-017-4571-3] [PMID: 29139007]
[51]
Sultan A, Choudhary V, Parganiha A. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles. Chronobiol Int 2017; 34(5): 609-23.
[http://dx.doi.org/10.1080/07420528.2017.1286501] [PMID: 28276853]
[52]
Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull 2010; 57(9): B4184.
[PMID: 20816024]
[53]
Takada K, Kashiwagi S, Goto W, et al. Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer. J Cancer Res Clin Oncol 2018; 144(8): 1547-59.
[http://dx.doi.org/10.1007/s00432-018-2670-0] [PMID: 29779135]
[54]
Charalambous A, Kaite CP, Charalambous M, Tistsi T, Kouta C. The effects on anxiety and quality of life of breast cancer patients following completion of the first cycle of chemotherapy. SAGE Open Med 2017; 5: 2050312117717507.
[http://dx.doi.org/10.1177/2050312117717507] [PMID: 28694967]
[55]
Härtl K, Engel J, Herschbach P, Reinecker H, Sommer H, Friese K. Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psychooncology 2010; 19(2): 160-9.
[http://dx.doi.org/10.1002/pon.1536] [PMID: 19189279]
[56]
Harris LN, Bauer MR, Wiley JF, et al. Chronic and episodic stress predict physical symptom bother following breast cancer diagnosis. J Behav Med 2017; 40(6): 875-85.
[http://dx.doi.org/10.1007/s10865-017-9855-x] [PMID: 28528393]
[57]
Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P. The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice? Breast 2017; 34: 44-52.
[http://dx.doi.org/10.1016/j.breast.2017.04.012] [PMID: 28500901]
[58]
Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology 2007; 16(9): 787-95.
[http://dx.doi.org/10.1002/pon.1120] [PMID: 17086555]
[59]
Servaes P, Verhagen CA, Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 2002; 95(9): 2017-26.
[http://dx.doi.org/10.1002/cncr.10891] [PMID: 12404297]
[60]
Nieboer P, Buijs C, Rodenhuis S, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol 2005; 23(33): 8296-304.
[http://dx.doi.org/10.1200/JCO.2005.10.167] [PMID: 16219926]
[61]
Bower JE, Wiley J, Petersen L, Irwin MR, Cole SW, Ganz PA. Fatigue after breast cancer treatment: Biobehavioral predictors of fatigue trajectories. Health Psychol 2018; 37(11): 1025-34.
[http://dx.doi.org/10.1037/hea0000652] [PMID: 30321021]
[62]
Zhang Q, Zhao H, Zheng Y. Effectiveness of mindfulness-based stress reduction (MBSR) on symptom variables and health-related quality of life in breast cancer patients-a systematic review and meta-analysis. Support Care Cancer 2018.
[http://dx.doi.org/10.1111/ecc.12632] [PMID: 30488223]
[63]
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 2011; 29(26): 3517-22.
[http://dx.doi.org/10.1200/JCO.2011.36.1154] [PMID: 21825266]
[64]
Liu L, Mills PJ, Rissling M, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 2012; 26(5): 706-13.
[http://dx.doi.org/10.1016/j.bbi.2012.02.001] [PMID: 22406004]
[65]
Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: A descriptive review. Brain Behav Immun 2016; 51: 1-11.
[http://dx.doi.org/10.1016/j.bbi.2015.06.012] [PMID: 26116436]
[66]
Bower JE. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 2014; 11(10): 597-609.
[http://dx.doi.org/10.1038/nrclinonc.2014.127] [PMID: 25113839]
[67]
Pais I, Correia N, Pimentel I, et al. Effects of acupuncture on leucopenia, neutropenia, NK, and B cells in cancer patients: a randomized pilot study. Evid Based Complement Alternat Med 2014; 2014: 217397.
[http://dx.doi.org/10.1155/2014/217397] [PMID: 25152759]
[68]
Lu W, Matulonis UA, Dunn JE, et al. The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial. Med Acupunct 2012; 24(4): 233-40.
[http://dx.doi.org/10.1089/acu.2012.0904] [PMID: 24761165]

Rights & Permissions Print Cite
Article Metrics
38
1
© 2024 Bentham Science Publishers | Privacy Policy